Asthma patients monitored on triple therapy in daily life
NCT ID NCT04902573
First seen Nov 01, 2025 · Last updated May 14, 2026 · Updated 31 times
Summary
This study followed 147 adults with moderate to severe asthma whose doctors prescribed the triple-combination inhaler Trimbow. Researchers observed how patients used the treatment in everyday settings and measured changes in asthma control, quality of life, and lung function. The goal was to understand real-world benefits and therapy patterns, not to test a new drug.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ASTHMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
The Haven Surgery, The Haven, Burnhope,
Durham, County Durham, DH7 0BD, United Kingdom
Conditions
Explore the condition pages connected to this study.